Literature DB >> 2475586

The significance of plasma phytanic acid levels in adults.

T C Britton1, F B Gibberd, M E Clemens, J D Billimoria, M C Sidey.   

Abstract

The presence of phytanic acid in tissues and plasma has been considered diagnostic of heredopathia atactica polyneuritiformis (Refsum's disease), but recently slightly raised plasma phytanic acid levels have been reported in other conditions. Forty two normal people were found to have a phytanic acid level of 0-33 mumol/l. Fourteen patients with heredopathia atactica polyneuritiformis had a plasma phytanic acid level before treatment of 992-6400 mumol/l. Five patients with retinitis pigmentosa but not heredopathia atactica polyneuritiformis had plasma levels of 38-192 mumol/l. It was concluded that some patients with retinitis pigmentosa without heredopathia atactica polyneuritiformis but a raised plasma phytanic acid may represent a group of patients with a disease or diseases as yet uncharacterised apart from the retinal condition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475586      PMCID: PMC1031939          DOI: 10.1136/jnnp.52.7.891

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins].

Authors:  M BURSTEIN; J SAMAILLE
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

2.  Atypical phenotype of Refsum's disease: clinical, biochemical, neurophysiological and pathological study.

Authors:  M T Dotti; A Rossi; N Rizzuto; G Hayek; N Bardelli; A M Bardelli; A Federico
Journal:  Eur Neurol       Date:  1985       Impact factor: 1.710

3.  The presence of phytanic acid in normal human and animal plasma.

Authors:  J Avigan
Journal:  Biochim Biophys Acta       Date:  1966-04-04

4.  Scanning the brain with various radioisotopes. Manual and automatic studies in a series of 750 patients.

Authors:  J H van Eck; M G Woldring
Journal:  Eur Neurol       Date:  1969       Impact factor: 1.710

5.  Diagnosis of Refsum's disease using [1-14C]phytanic acid as substrate.

Authors:  A Poulos
Journal:  Clin Genet       Date:  1981-10       Impact factor: 4.438

6.  Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.

Authors:  A Masters-Thomas; J Bailes; J D Billimoria; M E Clemens; F B Gibberd; N G Page
Journal:  J Hum Nutr       Date:  1980-08

7.  Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.

Authors:  F B Gibberd; J D Billimoria; N G Page; S Retsas
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

8.  Patterns of Refsum's disease. Phytanic acid oxidase deficiency.

Authors:  A Poulos; A C Pollard; J D Mitchell; G Wise; G Mortimer
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

9.  Ophthalmic manifestations of infantile phytanic acid storage disease.

Authors:  R G Weleber; A C Tongue; N G Kennaway; S S Budden; N R Buist
Journal:  Arch Ophthalmol       Date:  1984-09

10.  Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome?

Authors:  A Poulos; P Sharp; M Whiting
Journal:  Clin Genet       Date:  1984-12       Impact factor: 4.438

View more
  4 in total

1.  Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).

Authors:  D Harari; F B Gibberd; J P Dick; M C Sidey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

2.  Transport of phytanic acid on lipoproteins in Refsum disease.

Authors:  A S Wierzbicki; A Sankaralingam; P J Lumb; T C Hardman; M C Sidey; F B Gibberd
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

3.  Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.

Authors:  Alison J Price; Naomi E Allen; Paul N Appleby; Francesca L Crowe; Mazda Jenab; Sabina Rinaldi; Nadia Slimani; Rudolf Kaaks; Sabine Rohrmann; Heiner Boeing; Tobias Pischon; Vassiliki Benetou; Androniki Naska; Antonia Trichopoulou; Domenico Palli; Sabina Sieri; Rosario Tumino; Paolo Vineis; H Bas Bueno-de-Mesquita; Ignacio Donate; Carlos A González; Maria-José Sánchez; Maria-Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; Kay-Tee Khaw; Sheila Rodwell; Valentina Gallo; Dominique S Michaud; Elio Riboli; Timothy J Key
Journal:  Am J Clin Nutr       Date:  2010-04-28       Impact factor: 7.045

4.  Hypokalaemia in acute Refsum's disease.

Authors:  J P Dick; K Meeran; F B Gibberd; F C Rose
Journal:  J R Soc Med       Date:  1993-03       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.